Literature DB >> 24900215

[Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties.

Maria A Cinellu1, Laura Maiore1, Mario Manassero2, Angela Casini3, Massimiliano Arca4, Heinz-Herbert Fiebig5, Gerhard Kelter5, Elena Michelucci6, Giuseppe Pieraccini6, Chiara Gabbiani7, Luigi Messori7.   

Abstract

A novel dioxo-bridged dinuclear gold(III) complex with two 2,9-dimethylphenanthroline ligands was synthesized and thoroughly characterized. Its crystal structure was solved, and its solution behavior assessed. Remarkably, this compound revealed excellent antiproliferative properties in vitro against a wide panel of 36 cancer cell lines, combining a high cytotoxic potency to pronounced tumor selectivity. Very likely, these properties arise from an innovative mode of action (possibly involving histone deacetylase inhibition), as suggested by COMPARE analysis. In turn, electrospray ionization-mass spectrometry studies provided valuable insight into its molecular mechanisms of activation and of interaction with protein targets. Gold(III) reduction, dioxo bridge disruption, coordinative gold(I) binding to the protein, and concomitant release of the phenanthroline ligand were proposed to occur upon interaction with superoxide dismutase, used here as a model protein. Because of the reported results, this new gold(III) compound qualifies itself as an optimal candidate for further pharmacological testing.

Entities:  

Keywords:  COMPARE analysis; Cytotoxic gold compounds; anticancer agents; protein targets

Year:  2010        PMID: 24900215      PMCID: PMC4007953          DOI: 10.1021/ml100097f

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  18 in total

1.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

Review 2.  Polynuclear platinum drugs.

Authors:  Nicholas Farrell
Journal:  Met Ions Biol Syst       Date:  2004

3.  Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.

Authors:  Angela Casini; Maria Agostina Cinellu; Giovanni Minghetti; Chiara Gabbiani; Marcella Coronnello; Enrico Mini; Luigi Messori
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 4.  Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.

Authors:  Ruili Huang; Anders Wallqvist; David G Covell
Journal:  Biochem Pharmacol       Date:  2005-04-01       Impact factor: 5.858

5.  Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Authors:  Angela Casini; Chiara Gabbiani; Elena Michelucci; Giuseppe Pieraccini; Gloriano Moneti; Paul J Dyson; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-03-14       Impact factor: 3.358

Review 6.  Cisplatin: from DNA damage to cancer chemotherapy.

Authors:  S M Cohen; S J Lippard
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

Review 7.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

8.  Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.

Authors:  Raymond Wai-Yin Sun; Carrie Ka-Lei Li; Dik-Lung Ma; Jessie Jing Yan; Chun-Nam Lok; Chung-Hang Leung; Nianyong Zhu; Chi-Ming Che
Journal:  Chemistry       Date:  2010-03-08       Impact factor: 5.236

9.  Web-based tools for mining the NCI databases for anticancer drug discovery.

Authors:  Xueliang Fang; Lei Shao; Hui Zhang; Shaomeng Wang
Journal:  J Chem Inf Comput Sci       Date:  2004 Jan-Feb

10.  Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study.

Authors:  Angela Casini; Gerhard Kelter; Chiara Gabbiani; Maria Agostina Cinellu; Giovanni Minghetti; Dolores Fregona; Heinz-Herbert Fiebig; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-06-20       Impact factor: 3.358

View more
  13 in total

1.  DNA molecular recognition and cellular selectivity of anticancer metal(II) complexes of ethylenediaminediacetate and phenanthroline: multiple targets.

Authors:  Sze-Tin Von; Hoi-Ling Seng; Hong-Boon Lee; Seik-Weng Ng; Yusuke Kitamura; Makoto Chikira; Chew-Hee Ng
Journal:  J Biol Inorg Chem       Date:  2011-08-11       Impact factor: 3.358

2.  Synthesis, characterization, DFT study, DNA/BSA-binding affinity, and cytotoxicity of some dinuclear and trinuclear gold(III) complexes.

Authors:  Snežana Radisavljević; Dušan Ćoćić; Snežana Jovanović; Biljana Šmit; Marijana Petković; Nevena Milivojević; Nevena Planojević; Snežana Marković; Biljana Petrović
Journal:  J Biol Inorg Chem       Date:  2019-09-05       Impact factor: 3.358

3.  Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine.

Authors:  Zhen-Feng Chen; Yan-Cheng Liu; Yan Peng; Xue Hong; Hong-Hong Wang; Min-Min Zhang; Hong Liang
Journal:  J Biol Inorg Chem       Date:  2011-09-30       Impact factor: 3.358

4.  Synthesis, characterization, and stability of iron (III) complex ions possessing phenanthroline-based ligands.

Authors:  Shawnt Tosonian; Charles J Ruiz; Andrew Rios; Elma Frias; Jack F Eichler
Journal:  Open J Inorg Chem       Date:  2013-01-01

5.  Inhibition Mechanism of Urease by Au(III) Compounds Unveiled by X-ray Diffraction Analysis.

Authors:  Luca Mazzei; Margot N Wenzel; Michele Cianci; Marta Palombo; Angela Casini; Stefano Ciurli
Journal:  ACS Med Chem Lett       Date:  2019-01-04       Impact factor: 4.345

6.  The influence of oxo-bridged binuclear gold(III) complexes on Na/K-ATPase activity: a joint experimental and theoretical approach.

Authors:  Aleksandra M Bondžić; Mirjana B Čolović; Goran V Janjić; Božidarka Zarić; Sandra Petrović; Danijela Z Krstić; Tiziano Marzo; Luigi Messori; Vesna M Vasić
Journal:  J Biol Inorg Chem       Date:  2017-04-21       Impact factor: 3.358

7.  Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.

Authors:  Rui Peng; Guang-Xi Zhao; Jing Li; Yu Zhang; Xi-Zhong Shen; Ji-Yao Wang; Jian-Yong Sun
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

8.  Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme.

Authors:  Chiara Gabbiani; Lara Massai; Federica Scaletti; Elena Michelucci; Laura Maiore; Maria Agostina Cinellu; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2012-11-07       Impact factor: 3.358

9.  Selection and characterization of a human ovarian cancer cell line resistant to auranofin.

Authors:  Luigi Messori; Enrico Mini; Stefania Nobili; Ida Landini; Andrea Lapucci; Alessandro Pratesi; Lara Massai; Cristina Napoli; Gabriele Perrone; Pamela Pinzani
Journal:  Oncotarget       Date:  2017-10-09

10.  A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-delivery.

Authors:  Clive Yik-Sham Chung; Sin-Ki Fung; Ka-Chung Tong; Pui-Ki Wan; Chun-Nam Lok; Yanyu Huang; Tianfeng Chen; Chi-Ming Che
Journal:  Chem Sci       Date:  2016-11-22       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.